This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Alliance Pharma chief questioned in court appeal of drugmakers' UK antitrust fines

By Jon Menon ( June 8, 2023, 17:59 GMT | Insight) -- Alliance Pharmaceuticals’ chief executive faced questions in a London court today, including over the threat posed by a generic drug in the market, as the drugmaker and others argued that fines for breaking UK competition rules should be overturned. Alliance and others were sanctioned last year by the CMA, which said their behavior resulted in soaring prices for the state-funded healthcare service.Alliance Pharmaceuticals’ chief executive Peter Butterfield came under pressure from questions in a London court today as the drugmaker and others argued to have fines for breaking UK competition rules overturned....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections